We are live on !
Find out more
BAMCO Inc Portfolio holdings
AUM
$66.6B
Turnover
22.96%
1-Year Est. Return
7.35%
This Fund
S&P 500
This Quarter Est. Return
+0.82%
1 Year Est. Return
+7.35%
3 Year Est. Return
+62.2%
5 Year Est. Return
+84.27%
10 Year Est. Return
+776.55%
AUM
$36.9B
AUM Growth
-$802M
(-2.1%)
Cap. Flow
-$438M
Cap. Flow % of AUM
Cap. Flow %
-1.19%
Top 10 Holdings %
Top 10 Hldgs %
43.05%
Holding
363
New
33
Increased
122
Reduced
122
Closed
36
Avg Time Held
5.1
years
Top 10 Avg Time Held
6.3
years
Top 20 Avg Time Held
6.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Factset
FDS
|
+$300M |
| 2 |
MSCI
MSCI
|
+$203M |
| 3 |
Choice Hotels
CHH
|
+$193M |
| 4 |
Ventas
VTR
|
+$79.1M |
| 5 |
Birkenstock
BIRK
|
+$68.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gaming and Leisure Properties
GLPI
|
+$146M |
| 2 |
Vail Resorts
MTN
|
+$131M |
| 3 |
Cohen & Steers
CNS
|
+$102M |
| 4 |
Exact Sciences
EXAS
|
+$95.1M |
| 5 |
Vertiv
VRT
|
+$91.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.89% |
| 2 | Financials | 21.28% |
| 3 | Technology | 18.11% |
| 4 | Healthcare | 8.5% |
| 5 | Real Estate | 7.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
276
Agnico Eagle Mines
AEM
$96B
| $2.53M | 0.01% |
14,922
-6,544
| -30% | -$1.1M |
2022 Q1
15 quarters
|
|
277
HubSpot
HUBS
$11.5B
| $2.46M | 0.01% |
6,122
-3,180
| -34% | -$1.32M |
2021 Q1
19 quarters
|
|
278
Marriott Vacations Worldwide
VAC
$3.82B
| $2.41M | 0.01% |
41,800
| – | – |
2013 Q2
50 quarters
|
|
279
Vertex Pharmaceuticals
VRTX
$127B
| $2.36M | 0.01% |
5,200
| – | – |
2022 Q2
14 quarters
|
|
280
Insulet
PODD
$9.8B
| $2.24M | 0.01% |
7,886
+2,186
| +38% | +$683K |
2025 Q2
2 quarters
|
|
281
Vanguard Information Technology ETF
VGT
$146B
| $2.02M | 0.01% |
+21,456
| New | +$2.04M |
2025 Q4
0 quarters
|
|
282
UnitedHealth
UNH
$360B
| $1.98M | 0.01% |
6,000
+1,700
| +40% | +$576K |
2025 Q3
1 quarter
|
|
283
Encompass Health
EHC
$12.6B
| $1.86M | 0.01% |
17,500
| – | – |
2025 Q2
2 quarters
|
|
284
Micron Technology
MU
$994B
| $1.81M | ﹤0.01% |
+6,351
| New | +$1.46M |
2025 Q4
0 quarters
|
|
285
Elanco Animal Health
ELAN
$11.8B
| $1.81M | ﹤0.01% |
+80,000
| New | +$1.74M |
2025 Q4
0 quarters
|
|
286
Robinhood
HOOD
$88.9B
| $1.8M | ﹤0.01% |
15,950
-5,050
| -24% | -$657K |
2024 Q4
4 quarters
|
|
287
Robert Half
RHI
$3.41B
| $1.56M | ﹤0.01% |
57,600
| – | – |
2013 Q2
50 quarters
|
|
288
Kymera Therapeutics
KYMR
$8.71B
| $1.56M | ﹤0.01% |
20,000
+13,000
| +186% | +$878K |
2025 Q3
1 quarter
|
|
289
Capital One
COF
$124B
| $1.49M | ﹤0.01% |
6,135
+2,135
| +53% | +$475K |
2025 Q3
1 quarter
|
|
290
Madrigal Pharmaceuticals
MDGL
$10.4B
| $1.46M | ﹤0.01% |
2,500
-100
| -4% | -$51.1K |
2025 Q3
1 quarter
|
|
291
Novo Nordisk
NVO
$171B
| $1.4M | ﹤0.01% |
27,426
+5,985
| +28% | +$306K |
2023 Q4
8 quarters
|
|
292
Alnylam Pharmaceuticals
ALNY
$31B
| $1.39M | ﹤0.01% |
3,500
| – | – |
2025 Q3
1 quarter
|
|
293
Douglas Emmett
DEI
$1.63B
| $1.37M | ﹤0.01% |
124,363
-1,625,078
| -93% | -$20.4M |
2013 Q2
50 quarters
|
|
294
Xenon Pharmaceuticals
XENE
$3.24B
| $1.34M | ﹤0.01% |
30,000
| – | – |
2021 Q4
16 quarters
|
|
295
Ascendis Pharma A/S
ASND
$14.8B
| $1.19M | ﹤0.01% |
5,600
| – | – |
2025 Q3
1 quarter
|
|
296
Morgan Stanley
MS
$284B
| $1.17M | ﹤0.01% |
+6,600
| New | +$1.1M |
2025 Q4
0 quarters
|
|
297
Blackrock
BLK
$176B
| $1.13M | ﹤0.01% |
1,052
-48
| -4% | -$52.5K |
2018 Q1
31 quarters
|
|
298
Victory Capital Holdings
VCTR
$6.68B
| $1.05M | ﹤0.01% |
16,596
| – | – |
2022 Q4
12 quarters
|
|
299
Jack Henry & Associates
JKHY
$10.7B
| $932K | ﹤0.01% |
5,110
-890
| -15% | -$148K |
2020 Q1
23 quarters
|
|
300
Progressive
PGR
$127B
| $815K | ﹤0.01% |
3,580
-3,020
| -46% | -$682K |
2022 Q2
14 quarters
|
|
Similar funds
BAMCO Inc's Q4 2025 Portfolio in Review
As of Q4 2025, BAMCO Inc held 363 positions worth $36.9B, down 2.1% from $37.7B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
BAMCO Inc's Q4 2025 filing shows 33 new, 122 increased, 122 reduced and 36 closed positions. Its largest new stake was Champion Homes: 725,542 shares worth $61.3M. The largest sale was Gaming and Leisure Properties, an estimated $146M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 31% a quarter earlier, followed by Financials and Technology.
- BAMCO Inc's largest Q4 2025 buy was Champion Homes: 725,542 shares worth $61.3M.
- BAMCO Inc added most to Factset in Q4 2025, an estimated $300M increase.
- BAMCO Inc's biggest Q4 2025 reduction was Gaming and Leisure Properties, cutting an estimated $146M.
- BAMCO Inc fully exited Trex in Q4 2025, selling an estimated $82.1M.
- BAMCO Inc's ten largest holdings make up 43% of its $36.9B portfolio in Q4 2025.
- BAMCO Inc opened 33 new positions and closed 36 in Q4 2025.
- BAMCO Inc's portfolio value fell 2.1% quarter-over-quarter to $36.9B.
Based on BAMCO Inc's 13F filing for Q4 2025, filed 17 Feb 2026.